Patients are asking about peptides. Prescribers are curious. But is your pharmacy prepared for BPC‑157?
In a rapidly shifting therapeutic landscape, independent pharmacies can no longer afford to wait and see. Peptide therapies are gaining traction with both patients and providers, and the latest webinar hosted by Atrium24 with Olympia Pharmaceuticals dives deep into what’s hot, what’s legal, and what’s next.
Below, we’ll unpack key insights from the webinar (full replay embedded below), highlight direct quotes from Olympia’s leadership, and outline actionable steps independent pharmacy owners can take today to stay ahead.
🎥 Watch the Full Webinar
The Rising Demand for Peptides
“In the state of the world today, everyone is interested in peptides, even when they just hear the word.” – Dr. Anne West, Atrium24
Patients are increasingly driving conversations around wellness and performance therapies. From ligament repair to GI healing to anti-inflammatory benefits, peptides like BPC‑157 are capturing attention. Prescribers are fielding daily questions, which puts independent pharmacies in a prime position to educate, supply, and lead.
BPC‑157: Science Meets Compliance
Olympia’s leadership addressed the elephant in the room head-on:
“BPC‑157 is not a product that’s currently on the FDA’s bulks list or approved for any indication. That means it can’t be compounded yet.” – Josh Fritzler, Olympia
But Olympia is preparing:
- They’ve purchased API and placed BPC‑157 into research and development.
- Stability studies are underway to establish a beyond-use date.
- If the FDA adds it to the bulks list, Olympia will be ready to launch from their 503B facility.
This is a classic case of first-mover advantage. When the green light comes, pharmacies already aligned with Olympia and Atrium24’s GPO will be able to act fast.
New 503B Solutions from Olympia
While BPC‑157 remains in development, Olympia is rolling out therapies you can offer today:
- Liraglutide – A daily GLP‑1 alternative that addresses gaps left by semaglutide shortages.
- NAD+ (New Liquid Formulation) – “Double the product for half the price,” noted Olympia’s team, highlighting easier administration and reduced costs
- Sermorelin (Liquid Version Coming Soon) – Expected release later this year, eliminating reconstitution hassles.
- Wellness Bundles & Amino Blends – Weight-loss support, energy, and metabolism-focused injections designed for both office use and direct-to-patient.
These therapies not only meet patient demand but also provide new cash-based revenue opportunities for pharmacies.
The Atrium24 GPO Advantage
Atrium24 members gain exclusive pricing through our GPO partnership with Olympia:
- Discounts up to 30–50% on high-demand products like GLP‑1s, NAD+, and Sermorelin.
- No minimum orders – Start with just one vial to test patient demand.
- Fast turnaround – Most orders ship next day with full NDC numbers for seamless integration into your pharmacy management system
Anne West emphasized the simplicity:
“You order from Olympia, it comes next day with everything you need. It’s plug-and-play profitability for independent pharmacies.”
Action Steps for Independent Pharmacies
Here’s how you can act now to stay competitive:
- Educate Your Providers – Use Atrium24’s Olympia-specific order forms, bag stuffers, and sell sheets to spark prescriber conversations.
- Start Small, Scale Fast – Order a single vial of liraglutide or NAD+ and test demand with existing patients.
- Leverage Dotti CRM – Track prescriber conversations, manage follow-ups, and access branded marketing materials.
- Join the GPO – Save significantly on every Olympia order and access exclusive resources.
- Prepare for BPC‑157 – Position your pharmacy with Olympia now, so when regulations shift, you’re ready to move.
Conclusion
The future of peptides is closer than you think. Whether it’s BPC‑157 or Olympia’s current lineup of 503B therapies, pharmacies that act now will be positioned as leaders in wellness and patient care.
👉 Next Steps:
The question isn’t if peptides like BPC‑157 will arrive—it’s whether your pharmacy will be ready when they do.
This blog post is brought to you by Dotti, your partner in empowering independent pharmacies through advanced marketing and data analysis tools. With Dotti, transform the way you connect with prescribers and patients, and turn prescriber marketing into a cornerstone of your growth strategy. Learn more at www.atrium24.io
0 Comments